Apogee Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
APGE
56.80 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
43.93
52 week high
61.12
high
44.11
52 week low
28.79
low
41.75
growth
-16.33 %
previous Close
43.55
P/E ratio
market cap
2.71 B
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-49.02 M
-44.96 %
eps
0.00 %
-43.33 %
eps surprise
-16.22 %
net profit margin
-4901800000.00 %
0.00 %
operating incoming
-58.69 M
-33.01 %
net change in cash
-188.52 M
-5.82 %
cash on hand
119 M
-61.35 %
cost of revenue
0.00 %
top top